Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection

NCT04267809 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Singapore General Hospital

Collaborators